Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study
Interactions between macrophages and adipocytes are early molecular factors influencing adipose tissue (AT) dysfunction, resulting in high leptin, low adiponectin circulating levels and low-grade metaflammation, leading to insulin resistance (IR) with increased cardiovascular risk. We report the cha...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Adipocyte |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21623945.2020.1743116 |
id |
doaj-8577020c914e4732aeeacfa3a2386dda |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ernesto Rodriguez-Ayala Esther C. Gallegos-Cabrales Laura Gonzalez-Lopez Hugo A. Laviada-Molina Rocio A. Salinas-Osornio Edna J. Nava-Gonzalez Irene Leal-Berumen Claudia Escudero-Lourdes Fabiola Escalante-Araiza Fatima A. Buenfil-Rello Vanessa-Giselle Peschard Antonio Laviada-Nagel Eliud Silva Rosa A. Veloz-Garza Angelica Martinez-Hernandez Francisco M. Barajas-Olmos Fernanda Molina-Segui Lucia Gonzalez-Ramirez Rebeca Espadas-Olivera Ricardo Lopez-Muñoz Ruy D. Arjona-Villicaña Victor M. Hernandez-Escalante Martha E. Rodriguez-Arellano Janeth F. Gaytan-Saucedo Zoila Vaquera Monica Acebo-Martinez Judith Cornejo-Barrera Huertas-Quintero Jancy Andrea Juan Carlos Castillo-Pineda Areli Murillo-Ramirez Sara P. Diaz-Tena Benigno Figueroa-Nuñez Melesio E. Valencia-Rendon Rafael Garzon-Zamora Juan Manuel Viveros-Paredes José Ángeles-Chimal Jesús Santa-Olalla Tapia José M. Remes-Troche Salvador B. Valdovinos-Chavez Eira E. Huerta-Avila Juan Carlos Lopez-Alvarenga Anthony G Comuzzie Karin Haack Xianlin Han Lorena Orozco Susan Weintraub Jack W. Kent Shelley A. Cole Raul A. Bastarrachea |
spellingShingle |
Ernesto Rodriguez-Ayala Esther C. Gallegos-Cabrales Laura Gonzalez-Lopez Hugo A. Laviada-Molina Rocio A. Salinas-Osornio Edna J. Nava-Gonzalez Irene Leal-Berumen Claudia Escudero-Lourdes Fabiola Escalante-Araiza Fatima A. Buenfil-Rello Vanessa-Giselle Peschard Antonio Laviada-Nagel Eliud Silva Rosa A. Veloz-Garza Angelica Martinez-Hernandez Francisco M. Barajas-Olmos Fernanda Molina-Segui Lucia Gonzalez-Ramirez Rebeca Espadas-Olivera Ricardo Lopez-Muñoz Ruy D. Arjona-Villicaña Victor M. Hernandez-Escalante Martha E. Rodriguez-Arellano Janeth F. Gaytan-Saucedo Zoila Vaquera Monica Acebo-Martinez Judith Cornejo-Barrera Huertas-Quintero Jancy Andrea Juan Carlos Castillo-Pineda Areli Murillo-Ramirez Sara P. Diaz-Tena Benigno Figueroa-Nuñez Melesio E. Valencia-Rendon Rafael Garzon-Zamora Juan Manuel Viveros-Paredes José Ángeles-Chimal Jesús Santa-Olalla Tapia José M. Remes-Troche Salvador B. Valdovinos-Chavez Eira E. Huerta-Avila Juan Carlos Lopez-Alvarenga Anthony G Comuzzie Karin Haack Xianlin Han Lorena Orozco Susan Weintraub Jack W. Kent Shelley A. Cole Raul A. Bastarrachea Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study Adipocyte adipose tissue dysfunction immunometabolism postprandial tissue biopsies non-coding micrornas shotgun lipidomics |
author_facet |
Ernesto Rodriguez-Ayala Esther C. Gallegos-Cabrales Laura Gonzalez-Lopez Hugo A. Laviada-Molina Rocio A. Salinas-Osornio Edna J. Nava-Gonzalez Irene Leal-Berumen Claudia Escudero-Lourdes Fabiola Escalante-Araiza Fatima A. Buenfil-Rello Vanessa-Giselle Peschard Antonio Laviada-Nagel Eliud Silva Rosa A. Veloz-Garza Angelica Martinez-Hernandez Francisco M. Barajas-Olmos Fernanda Molina-Segui Lucia Gonzalez-Ramirez Rebeca Espadas-Olivera Ricardo Lopez-Muñoz Ruy D. Arjona-Villicaña Victor M. Hernandez-Escalante Martha E. Rodriguez-Arellano Janeth F. Gaytan-Saucedo Zoila Vaquera Monica Acebo-Martinez Judith Cornejo-Barrera Huertas-Quintero Jancy Andrea Juan Carlos Castillo-Pineda Areli Murillo-Ramirez Sara P. Diaz-Tena Benigno Figueroa-Nuñez Melesio E. Valencia-Rendon Rafael Garzon-Zamora Juan Manuel Viveros-Paredes José Ángeles-Chimal Jesús Santa-Olalla Tapia José M. Remes-Troche Salvador B. Valdovinos-Chavez Eira E. Huerta-Avila Juan Carlos Lopez-Alvarenga Anthony G Comuzzie Karin Haack Xianlin Han Lorena Orozco Susan Weintraub Jack W. Kent Shelley A. Cole Raul A. Bastarrachea |
author_sort |
Ernesto Rodriguez-Ayala |
title |
Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
title_short |
Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
title_full |
Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
title_fullStr |
Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
title_full_unstemmed |
Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
title_sort |
towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the gemm family study |
publisher |
Taylor & Francis Group |
series |
Adipocyte |
issn |
2162-3945 2162-397X |
publishDate |
2020-01-01 |
description |
Interactions between macrophages and adipocytes are early molecular factors influencing adipose tissue (AT) dysfunction, resulting in high leptin, low adiponectin circulating levels and low-grade metaflammation, leading to insulin resistance (IR) with increased cardiovascular risk. We report the characterization of AT dysfunction through measurements of the adiponectin/leptin ratio (ALR), the adipo-insulin resistance index (Adipo-IRi), fasting/postprandial (F/P) immunometabolic phenotyping and direct F/P differential gene expression in AT biopsies obtained from symptom-free adults from the GEMM family study. AT dysfunction was evaluated through associations of the ALR with F/P insulin-glucose axis, lipid-lipoprotein metabolism, and inflammatory markers. A relevant pattern of negative associations between decreased ALR and markers of systemic low-grade metaflammation, HOMA, and postprandial cardiovascular risk hyperinsulinemic, triglyceride and GLP-1 curves was found. We also analysed their plasma non-coding microRNAs and shotgun lipidomics profiles finding trends that may reflect a pattern of adipose tissue dysfunction in the fed and fasted state. Direct gene differential expression data showed initial patterns of AT molecular signatures of key immunometabolic genes involved in AT expansion, angiogenic remodelling and immune cell migration. These data reinforce the central, early role of AT dysfunction at the molecular and systemic level in the pathogenesis of IR and immunometabolic disorders. |
topic |
adipose tissue dysfunction immunometabolism postprandial tissue biopsies non-coding micrornas shotgun lipidomics |
url |
http://dx.doi.org/10.1080/21623945.2020.1743116 |
work_keys_str_mv |
AT ernestorodriguezayala towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT esthercgallegoscabrales towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT lauragonzalezlopez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT hugoalaviadamolina towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT rocioasalinasosornio towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT ednajnavagonzalez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT irenelealberumen towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT claudiaescuderolourdes towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT fabiolaescalantearaiza towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT fatimaabuenfilrello towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT vanessagisellepeschard towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT antoniolaviadanagel towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT eliudsilva towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT rosaavelozgarza towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT angelicamartinezhernandez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT franciscombarajasolmos towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT fernandamolinasegui towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT luciagonzalezramirez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT rebecaespadasolivera towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT ricardolopezmunoz towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT ruydarjonavillicana towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT victormhernandezescalante towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT marthaerodriguezarellano towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT janethfgaytansaucedo towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT zoilavaquera towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT monicaacebomartinez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT judithcornejobarrera towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT huertasquinterojancyandrea towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT juancarloscastillopineda towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT arelimurilloramirez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT sarapdiaztena towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT benignofigueroanunez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT melesioevalenciarendon towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT rafaelgarzonzamora towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT juanmanuelviverosparedes towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT joseangeleschimal towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT jesussantaolallatapia towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT josemremestroche towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT salvadorbvaldovinoschavez towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT eiraehuertaavila towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT juancarloslopezalvarenga towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT anthonygcomuzzie towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT karinhaack towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT xianlinhan towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT lorenaorozco towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT susanweintraub towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT jackwkent towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT shelleyacole towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy AT raulabastarrachea towardsprecisionmedicinedefiningandcharacterizingadiposetissuedysfunctiontoidentifyearlyimmunometabolicriskinsymptomfreeadultsfromthegemmfamilystudy |
_version_ |
1721300691851411456 |
spelling |
doaj-8577020c914e4732aeeacfa3a2386dda2021-07-15T13:47:54ZengTaylor & Francis GroupAdipocyte2162-39452162-397X2020-01-019115316910.1080/21623945.2020.17431161743116Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family studyErnesto Rodriguez-Ayala0Esther C. Gallegos-Cabrales1Laura Gonzalez-Lopez2Hugo A. Laviada-Molina3Rocio A. Salinas-Osornio4Edna J. Nava-Gonzalez5Irene Leal-Berumen6Claudia Escudero-Lourdes7Fabiola Escalante-Araiza8Fatima A. Buenfil-Rello9Vanessa-Giselle Peschard10Antonio Laviada-Nagel11Eliud Silva12Rosa A. Veloz-Garza13Angelica Martinez-Hernandez14Francisco M. Barajas-Olmos15Fernanda Molina-Segui16Lucia Gonzalez-Ramirez17Rebeca Espadas-Olivera18Ricardo Lopez-Muñoz19Ruy D. Arjona-Villicaña20Victor M. Hernandez-Escalante21Martha E. Rodriguez-Arellano22Janeth F. Gaytan-Saucedo23Zoila Vaquera24Monica Acebo-Martinez25Judith Cornejo-Barrera26Huertas-Quintero Jancy Andrea27Juan Carlos Castillo-Pineda28Areli Murillo-Ramirez29Sara P. Diaz-Tena30Benigno Figueroa-Nuñez31Melesio E. Valencia-Rendon32Rafael Garzon-Zamora33Juan Manuel Viveros-Paredes34José Ángeles-Chimal35Jesús Santa-Olalla Tapia36José M. Remes-Troche37Salvador B. Valdovinos-Chavez38Eira E. Huerta-Avila39Juan Carlos Lopez-Alvarenga40Anthony G Comuzzie41Karin Haack42Xianlin Han43Lorena Orozco44Susan Weintraub45Jack W. Kent46Shelley A. Cole47Raul A. Bastarrachea48Universidad Anáhuac NorteUniversidad Autónoma de Nuevo León (UANL)Universidad del Valle de Atemajac (UNIVA)Universidad Marista de MéridaUniversidad del Valle de Atemajac (UNIVA)UANLUniversidad Autónoma de ChihuahuaUniversidad Autónoma de San Luis PotosíUniversidad Anáhuac NorteTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Universidad Anáhuac NorteTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Universidad Anáhuac NorteUniversidad Autónoma de Nuevo León (UANL)Instituto Nacional de Medicina GenómicaInstituto Nacional de Medicina GenómicaUniversidad Marista de MéridaUniversidad Marista de MéridaUniversidad Marista de MéridaUniversidad Marista de MéridaUniversidad Marista de MéridaTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)ISSSTETexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Texas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Universidad Autónoma de San Luis PotosíPostgrado e Investigación, Hospital Infantil de TamaulipasTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Universidad Latina de AméricaUniversidad Latina de AméricaUniversidad Latina de AméricaClínica de Enfermedades Crónicas y Procedimientos Especiales (CECYPE)Universidad del Valle de Atemajac (UNIVA)Universidad del Valle de Atemajac (UNIVA)Universidad del Valle de Atemajac (UNIVA)Universidad Autónoma Estado de MorelosUniversidad Autónoma Estado de MorelosUniversidad VeracruzanaUniversidad Autónoma de Nuevo León (UANL)Instituto Nacional de Medicina GenómicaUniversity of Texas Rio Grande ValleyThe Obesity SocietyTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)University of Texas Health San AntonioInstituto Nacional de Medicina GenómicaUniversity of Texas Health Science CenterTexas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Texas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Texas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC)Interactions between macrophages and adipocytes are early molecular factors influencing adipose tissue (AT) dysfunction, resulting in high leptin, low adiponectin circulating levels and low-grade metaflammation, leading to insulin resistance (IR) with increased cardiovascular risk. We report the characterization of AT dysfunction through measurements of the adiponectin/leptin ratio (ALR), the adipo-insulin resistance index (Adipo-IRi), fasting/postprandial (F/P) immunometabolic phenotyping and direct F/P differential gene expression in AT biopsies obtained from symptom-free adults from the GEMM family study. AT dysfunction was evaluated through associations of the ALR with F/P insulin-glucose axis, lipid-lipoprotein metabolism, and inflammatory markers. A relevant pattern of negative associations between decreased ALR and markers of systemic low-grade metaflammation, HOMA, and postprandial cardiovascular risk hyperinsulinemic, triglyceride and GLP-1 curves was found. We also analysed their plasma non-coding microRNAs and shotgun lipidomics profiles finding trends that may reflect a pattern of adipose tissue dysfunction in the fed and fasted state. Direct gene differential expression data showed initial patterns of AT molecular signatures of key immunometabolic genes involved in AT expansion, angiogenic remodelling and immune cell migration. These data reinforce the central, early role of AT dysfunction at the molecular and systemic level in the pathogenesis of IR and immunometabolic disorders.http://dx.doi.org/10.1080/21623945.2020.1743116adipose tissue dysfunctionimmunometabolismpostprandial tissue biopsiesnon-coding micrornasshotgun lipidomics |